Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Clinical trial NCT01833208 · COMPLETED

Trial details

NCT number: NCT01833208
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Malignant Neoplasm in the Bone Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2013-07-03
Primary completion: 2018-08-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.